tiotropium/salmeterol inhalation powder

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for tiotropium/salmeterol inhalation powder, covering 2023-11-07 to 2026-07-16. Get the full timeline:

Most recent: Clinical Trial Results: Tiotropium/Salmeterol Inhalation Powder in COPD [Phase 3]